Teradyne climbed 6.3% on Tuesday to $392.62 — its biggest single-session gain in weeks — yet short sellers have spent the past month quietly rebuilding positions, creating an unusual tension between a stock reaching new highs and a bear camp growing more crowded.
Short interest has risen notably, up 17% over the past week and 22% over the past month to reach 3.9% of the free float. That brings the short book to roughly 6.1 million shares — the highest it has been across the 30-day window in the snapshot. The surge in shorts is concentrated in the last two weeks of May, when positions jumped from around 5.2 million shares to over 6.1 million in a matter of days. What makes this less alarming than it sounds: the borrow market is entirely unstressed. Cost to borrow is running at just 0.33%, down 17% on the week and nearly 29% over the past month. Availability is effectively unlimited — the lending pool holds far more shares than bears could realistically absorb at current position sizes. This is a stock where shorts face no squeeze mechanics; the position build is a directional bet, not a trapped one.
Options tell a different story from the short sellers. The put/call ratio has eased to 0.73, now sitting roughly 0.9 standard deviations below its 20-day average of 0.77. That's the lowest reading in several weeks and the opposite of what you'd expect from a market worried about Teradyne's near-term outlook. In other words, options traders appear to be leaning into Tuesday's rally rather than hedging against it — a sharp contrast with the short book's growing conviction. The ORTEX short score is a moderate 33.4, well within mid-range territory and barely changed across the past two weeks, confirming that the broader short-sentiment picture has not turned aggressively bearish despite the position build.
The Street is broadly constructive. The cluster of analyst moves around the April 30 post-earnings session told a clear story: JP Morgan upgraded to Overweight, Citigroup raised its target from $325 to $400 (Buy), Goldman Sachs moved from $300 to $350 (Buy), and Stifel lifted to $390. Evercore ISI was the outlier, trimming its target from $430 to $370 after an earlier pre-earnings raise — a sign that one firm sees the post-earnings price level as fair value rather than a launchpad. The consensus mean price target is $375, modestly below Tuesday's close of $392, suggesting the stock has now outrun the average Street target after its recent run. The bull case rests on AI semiconductor test revenue exceeding 50% of the mix and HDD test volumes potentially doubling by year-end. Bears focus on execution risk in industrial automation, US-China trade friction, and the risk that AI infrastructure capex cycles turn more lumpy than the current consensus assumes.
Insider activity adds a note of caution. Every transaction logged over the past 90 days has been a sale, collectively totalling around $5.8 million in net value sold. The most significant was CEO Gregory Smith's May 15 disposal of 8,597 shares at $338.98 — approximately $2.9 million. Division president Shannon Poulin sold across multiple tranches in late May. None of these trades carry high significance scores, and the volumes are small relative to the $61 billion market cap. But the consistent direction — no buying, only selling — is worth noting in a week where the stock just hit a fresh high.
The earnings history adds another dimension. The Q1 2026 print on April 28-29 produced a sharp one-day drop of nearly 24%, with a further 11% decline over the following five days. The stock subsequently recovered almost all of that move — the 1% one-week reading for the same event reflects the bounce — but the reaction pattern suggests the market treats Teradyne earnings as binary events with significant downside risk on any miss or guidance disappointment. The next print is scheduled for July 29. Between now and then, the key variable is whether the AI semiconductor test ramp continues to offset the softness in mobile and industrial automation that has weighed on the business — and whether the short book, which has quietly grown by a fifth over the past month, starts to unwind or continues to build into the next catalyst.
See the live data behind this article on ORTEX.
Open TER on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
